ViaDerma, Inc. (VDRM)
OTCMKTS · Delayed Price · Currency is USD
0.0120
+0.0003 (2.56%)
Apr 25, 2025, 4:00 PM EDT

ViaDerma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2017 FY 2016 FY 2015 FY 2011 FY 2010 2007 - 2009
Period Ending
Dec '17 Dec '16 Dec '15 Dec '11 Dec '10 2007 - 2009
Net Income
-1.52-0.120.032.674.51
Upgrade
Depreciation & Amortization
0002.811.56
Upgrade
Other Amortization
0.30.150.02-0.86
Upgrade
Loss (Gain) From Sale of Assets
---00
Upgrade
Stock-Based Compensation
0.33-0.04--
Upgrade
Other Operating Activities
0.610.06-0.05--
Upgrade
Change in Accounts Receivable
-0.02-0.2-0.170.620.09
Upgrade
Change in Inventory
-0.02-000.670.43
Upgrade
Change in Accounts Payable
----0.15-0.31
Upgrade
Change in Income Taxes
----0.3-0.15
Upgrade
Change in Other Net Operating Assets
0.150.10.12-0.260.79
Upgrade
Operating Cash Flow
-0.17-0.01-0.016.057.78
Upgrade
Operating Cash Flow Growth
----22.15%135.09%
Upgrade
Capital Expenditures
----9.43-7.13
Upgrade
Sale of Property, Plant & Equipment
---00
Upgrade
Investing Cash Flow
----9.43-7.12
Upgrade
Short-Term Debt Issued
0.170.020.011.81.48
Upgrade
Long-Term Debt Issued
---3.11.03
Upgrade
Total Debt Issued
0.170.020.014.92.51
Upgrade
Short-Term Debt Repaid
----1.74-1.82
Upgrade
Long-Term Debt Repaid
----0.2-1.13
Upgrade
Total Debt Repaid
----1.95-2.95
Upgrade
Net Debt Issued (Repaid)
0.170.020.012.95-0.45
Upgrade
Financing Cash Flow
0.170.020.012.95-0.45
Upgrade
Foreign Exchange Rate Adjustments
---0.03-0.01
Upgrade
Net Cash Flow
00.01-0-0.390.2
Upgrade
Free Cash Flow
-0.17-0.01-0.01-3.380.65
Upgrade
Free Cash Flow Margin
-374.49%-4.79%-5.83%-17.77%2.43%
Upgrade
Free Cash Flow Per Share
----24.604.74
Upgrade
Cash Interest Paid
---0.410.19
Upgrade
Cash Income Tax Paid
---1.182.15
Upgrade
Levered Free Cash Flow
0.69-0.2--4.46-1.11
Upgrade
Unlevered Free Cash Flow
0.63-0.2--4.15-0.32
Upgrade
Change in Net Working Capital
-0.650.28-0.050.81
Upgrade
Updated May 3, 2018. Source: S&P Global Market Intelligence. Standard template. Financial Sources.